Douglas M. Brown's most recent trade in Neogenomics Inc. was a trade of 82,305 Common Stock done . Disclosure was reported to the exchange on April 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 82,305 | 158,684 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 85,519 | 85,519 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 35,030 | 77,246 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2022 | 867 | 76,379 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2021 | 30,572 | 42,216 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 36.85 per share. | 23 Nov 2021 | 33,334 | 11,644 (0%) | 0% | 36.9 | 1,228,358 | Common Stock |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 36.84 per share. | 23 Nov 2021 | 33,333 | 44,978 (0%) | 0% | 36.8 | 1,227,988 | Common Stock |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 37.19 per share. | 23 Nov 2021 | 33,333 | 78,311 (0%) | 0% | 37.2 | 1,239,654 | Common Stock |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 26,378 | 26,378 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Douglas M. Brown | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 4,655 | 111,644 (0%) | 0% | 0 | Common Stock |